ATE513851T1 - Menschliches gen zur fruchtbarkeit entscheidend - Google Patents

Menschliches gen zur fruchtbarkeit entscheidend

Info

Publication number
ATE513851T1
ATE513851T1 AT01923130T AT01923130T ATE513851T1 AT E513851 T1 ATE513851 T1 AT E513851T1 AT 01923130 T AT01923130 T AT 01923130T AT 01923130 T AT01923130 T AT 01923130T AT E513851 T1 ATE513851 T1 AT E513851T1
Authority
AT
Austria
Prior art keywords
mater
protein
fertility
subject
detecting
Prior art date
Application number
AT01923130T
Other languages
English (en)
Inventor
Lawrence Nelson
Zhi-Bin Tong
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE513851T1 publication Critical patent/ATE513851T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/361—Menstrual abnormalities or abnormal uterine bleeding, e.g. dysmenorrhea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos
AT01923130T 2000-10-18 2001-04-04 Menschliches gen zur fruchtbarkeit entscheidend ATE513851T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24151000P 2000-10-18 2000-10-18
PCT/US2001/010981 WO2002032955A1 (en) 2000-10-18 2001-04-04 Human gene critical to fertility

Publications (1)

Publication Number Publication Date
ATE513851T1 true ATE513851T1 (de) 2011-07-15

Family

ID=22910969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01923130T ATE513851T1 (de) 2000-10-18 2001-04-04 Menschliches gen zur fruchtbarkeit entscheidend

Country Status (7)

Country Link
US (4) US7217811B2 (de)
EP (1) EP1328545B1 (de)
JP (1) JP4744062B2 (de)
AT (1) ATE513851T1 (de)
AU (2) AU4985201A (de)
CA (1) CA2425174C (de)
WO (1) WO2002032955A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217811B2 (en) 2000-10-18 2007-05-15 The United States Of America As Represented By The Department Of Health And Human Services Human gene critical to fertility
WO2002081492A1 (en) * 2001-04-04 2002-10-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human gene critical to fertility
AU2002243234A1 (en) * 2000-11-15 2002-06-24 Incyte Genomics, Inc. Embryogenesis associated proteins
EP1515981A2 (de) * 2001-01-31 2005-03-23 Millennium Pharmaceuticals, Inc. Neue moleküle der pyrin/nbs/lrr-proteinfamilie und deren verwendungen
US7041643B2 (en) 2001-01-31 2006-05-09 Millennium Pharmaceuticals, Inc. Molecules of the PYRIN/NBS/LRR protein family and uses thereof
DE10139874A1 (de) * 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
WO2008066483A1 (en) * 2006-11-27 2008-06-05 Mohammad Alimohammadi Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders
KR20120100938A (ko) * 2009-09-23 2012-09-12 셀매틱스, 인크. 불임 및/또는 난자 품질을 평가하기 위한 방법 및 장치
US8778618B2 (en) 2010-04-16 2014-07-15 The Johns Hopkins University Compositions and methods for characterizing a myopathy
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
WO2015051191A1 (en) * 2013-10-02 2015-04-09 Northeastern University Methods and compositions for generation of developmentally-incompetent eggs in recipients of nuclear genetic transfer
CA2954895A1 (en) 2014-07-17 2016-01-21 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
MA45408A (fr) 2016-06-17 2019-04-24 Magenta Therapeutics Inc Compositions et procédés pour la déplétion des cellules cd117+
US10576161B2 (en) 2017-01-20 2020-03-03 Magenta Therapeutics, Inc. Compositions and methods for the depletion of CD137+ cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
WO1993024135A1 (en) * 1992-05-26 1993-12-09 Immunex Corporation Novel cytokine that binds cd30
DE69333610D1 (de) 1992-11-09 2004-10-07 Zonagen Inc Methoden für die immunoempfängnisverhütung
US5637300A (en) 1994-08-03 1997-06-10 Dunbar; Bonnie S. Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception
US7217811B2 (en) 2000-10-18 2007-05-15 The United States Of America As Represented By The Department Of Health And Human Services Human gene critical to fertility
AU2002243234A1 (en) 2000-11-15 2002-06-24 Incyte Genomics, Inc. Embryogenesis associated proteins
US20040043452A1 (en) * 2001-11-14 2004-03-04 Jayalaxmi Ramkumar Embryogenesis associated proteins

Also Published As

Publication number Publication date
US7432067B2 (en) 2008-10-07
EP1328545B1 (de) 2011-06-22
AU2001249852B2 (en) 2006-10-19
EP1328545A1 (de) 2003-07-23
US7531635B2 (en) 2009-05-12
JP4744062B2 (ja) 2011-08-10
CA2425174C (en) 2013-07-30
CA2425174A1 (en) 2002-04-25
US20040072297A1 (en) 2004-04-15
US7189812B2 (en) 2007-03-13
US20070037218A1 (en) 2007-02-15
US20040028669A1 (en) 2004-02-12
AU4985201A (en) 2002-04-29
US7217811B2 (en) 2007-05-15
US20070105153A1 (en) 2007-05-10
JP2004534504A (ja) 2004-11-18
WO2002032955A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
Flach et al. The transition from maternal to embryonic control in the 2‐cell mouse embryo.
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
ATE419388T1 (de) Nukleinsäureanreicherung
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
WO2002055985A3 (en) Methods and reagents for identifying rare fetal cells in the material circulation
ATE251304T1 (de) Verfahren und zusammensetzungen zur beobachtung der zellulären verarbeitung von beta-amyloid- vorläuferproteinen
WO2002046465A3 (en) Method for identification of genes involved in specific diseases
CN104540849A (zh) 新的干扰素λ4(IFNL4)蛋白、相关核酸分子、及其用途
ES2185146T3 (es) Receptores de netrina.
WO2004009758A3 (en) Embryonic stem cell markers and uses thereof
AU2003296085A1 (en) Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
MXPA02010868A (es) Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera.
DE602004030036D1 (de) Multiplexanalyse von Nukleinsäuren zur Bestimmung von Genotypen des humanen Papillomavirus
ATE362526T1 (de) Ceramidasegen
SE9900615L (sv) Metod och kit för tidig förutsägelse av cancer
DE60025011D1 (de) Dna polymerase lambda und ihre verwendungen
WO2004078915A3 (en) Cell culture
MXPA02004825A (es) Genes especificamente expresados en celulas dendriticas humanas.
WO2005049791A3 (en) Identification of reagents for the diagnosis and study of francisella
WO2002018562A1 (fr) Enzymes de type trypsine propres aux voies respiratoires et leur procede d'utilisation
DE60334408D1 (de) Nsäuren
WO2002086113A3 (en) Enzyme and snp marker for disease
DE60132323D1 (de) Frühen diagnose von blasentumor in urinproben
WO2006023211A3 (en) Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties